CD8A and neoplasm: N-acetyltransferase 8-like (NAT8L) inhibits the cytotoxicity of NK cells and CD8+ T cells via N-acetylaspartate (NAA), thereby reducing brain inflammation while simultaneously undermining anti-tumor immunity [155].